On being “actionable”: clinical sequencing and the emerging contours of a regime of genomic medicine in oncology

References

• Allegra, Carmen J., J. Milburn Jessup, Mark R. Somerfield, Stanley R. Hamilton, Elizabeth H. Hammond, Daniel F. Hayes, Pamela K. McAllister, Roscoe F. Morton, and Richard L. Schilsky. 2009. “American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy.” Journal of Clinical Oncology 27 (12): 2091–2096. doi: 10.1200/JCO.2009.21.9170
   PubMed Web of Science ®Google Scholar
• Amin, Ash, and Patrick Cohendet. 2004. Architectures of Knowledge: Firms, Capabilities, and Communities. Oxford: Oxford University Press.
   Google Scholar
• André, Fabrice, Frederique Nowak, Monica Arnedos, Ludovic Lacroix, Patrice Viens, and Fabien Calvo. 2012. “Biomarker Discovery, Development, and Implementation in France: A Report from the French National Cancer Institute and Cooperative Groups.” Clinical Cancer 18 (6): 1555–1560. doi: 10.1158/1078-0432.CCR-11-2201
   Web of Science ®Google Scholar
• Baszanger, Isabelle. 2012. “One More Chemo or One Too Many? Defining the Limits of Treatment and Innovation in Medical Oncology.” Social Science & Medicine 75 (5): 864–872. doi: 10.1016/j.socscimed.2012.03.023
   PubMed Web of Science ®Google Scholar
• Bourret, Pascale. 2005. “BRCA Patients and Clinical Collectives New Configurations of Action in Cancer Genetics Practices.” Social Studies of Science 35 (1): 41–68. doi: 10.1177/0306312705048716
   PubMed Web of Science ®Google Scholar
• Bourret, Pascale, Peter Keating, and Alberto Cambrosio. 2011. “Regulating Diagnosis in Post-genomic Medicine: Re-aligning Clinical Judgment?” Social Science & Medicine 73 (6): 816–824. doi: 10.1016/j.socscimed.2011.04.022
   PubMed Web of Science ®Google Scholar
• Brunham, Liam R., and Michael R. Hayden. 2012. “Whole-Genome Sequencing: The New Standard of Care?” Science 336 (6085): 1112–1113. doi: 10.1126/science.1220967
   PubMed Web of Science ®Google Scholar
• Buettner, Reinhard, Jürgen Wolf, and Roman K. Thomas. 2013. “Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment.” Journal of Clinical Oncology 31 (15): 1858–1865. doi: 10.1200/JCO.2012.45.9867
   PubMed Web of Science ®Google Scholar
• Butler, Declan. 2008. “Translational Research: Crossing the Valley of Death.” Nature News 453 (7197): 840–842. doi: 10.1038/453840a
   PubMed Web of Science ®Google Scholar
• Callon, Michel. 2012. “Les incertititudes scientifiques et techniques constituent-elles une source possible de renouvellement de la vie démocratique?” 028. Papiers de Recherche du CSI. Paris: Centre de Sociologie de l'Innovation, Mines ParisTech. http://www.csi.ensmp.fr/working-papers/WP/WP_CSI_028.pdf
   Google Scholar
• Cambrosio, Alberto, Peter Keating, Thomas Schlich, and George Weisz. 2006. “Regulatory Objectivity and the Generation and Management of Evidence in Medicine.” Social Science & Medicine 63 (1): 189–199. doi: 10.1016/j.socscimed.2005.12.007
   PubMed Web of Science ®Google Scholar
• Christakis, Nicholas A. 1999. Death Foretold: Prophecy and Prognosis in Medical Care. Chicago, IL: University of Chicago Press.
   Google Scholar
• Dias-Santagata, Dora, Sara Akhavanfard, Serena S. David, Kathy Vernovsky, Georgiana Kuhlmann, Susan L. Boisvert, Hannah Stubbs, et al. 2010. “Rapid Targeted Mutational Analysis of Human Tumours: A Clinical Platform to Guide Personalized Cancer Medicine.” EMBO Molecular Medicine 2 (5): 146–158. doi: 10.1002/emmm.201000070
   PubMed Web of Science ®Google Scholar
• Drmanac, Radoje. 2012. “The Ultimate Genetic Test.” Science 336 (6085): 1110–1112. doi: 10.1126/science.1221037
   PubMed Web of Science ®Google Scholar
• Duff, Linea. 2013. “About | Life and Breath: Outliving Lung Cancer.” Accessed June 25. http://outlivinglungcancer.com/about/
   Google Scholar
• Fox, Renée C. 2003. “Medical Uncertainty Revisited.” In Handbook of Social Studies in Health and Medicine, edited by Gaby L. Albrecht, Ray Fitzpatrick, and Susan C. Scrimshaw, 409–425. Thousand Oaks, CA: Sage.
   Google Scholar
• Freidlin, Boris, Lisa M. McShane, and Edward L. Korn. 2010. “Randomized Clinical Trials with Biomarkers: Design Issues.” Journal of the National Cancer Institute 102 (3): 152–160. doi: 10.1093/jnci/djp477
   PubMed Web of Science ®Google Scholar
• “Getting Personal.” 2011. Nature 473 (7347): 253–254. doi:10.1038/473253b.
   Web of Science ®Google Scholar
• Gibbon, Sahra, Eirini Kampriani, and Andrea zur Nieden. 2010. “BRCA Patients in Cuba, Greece and Germany: Comparative Perspectives on Public Health, the State and the Partial Reproduction of ‘Neoliberal’ Subjects.” BioSocieties 5 (4): 440–466. doi: 10.1057/biosoc.2010.28
   PubMed Web of Science ®Google Scholar
• Heger, Monica. 2011. “UK Government Funding Development of Sequencing-Based Cancer Tests.” GenomeWeb, June 21. http://www.genomeweb.com/sequencing/uk-government-funding-development-sequencing-based-cancer-tests
   Google Scholar
• Heger, Monica. 2012a. “Sequencing Breaks into the Clinic in 2011, but Ethical, Regulatory, and Technical Hurdles Remain.” GenomeWeb, January 4. http://www.genomeweb.com/sequencing/sequencing-breaks-clinic-2011-ethical-regulatory-and-technical-hurdles-remain
   Google Scholar
• Heger, Monica. 2012b. “Cancer Sequencing Takes off in 2011 Amid Debate on Benefits of Targeted vs. Comprehensive Approaches.” Genome Web, January 11. http://www.genomeweb.com/sequencing/cancer-sequencing-takes-2011-amid-debate-benefits-targeted-vs-comprehensive-appr
   Google Scholar
• Institut Curie. 2012. “SHIVA: Le premier essai clinique uniquement basé sur le profil biologique de la tumeur”. Press Release, November 9. Paris. http://curie.fr/sites/default/files/cp-shiva-raid-recherche-clinique.pdf
   Google Scholar
• Jackman, David M., Vincent A. Miller, Leigh-Anne Cioffredi, Beow Y. Yeap, Pasi A. Jänne, Gregory J. Riely, Marielle Gallegos Ruiz, et al. 2009. “Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non-Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials.” Clinical Cancer Research 15 (16): 5267–5273. doi: 10.1158/1078-0432.CCR-09-0888
   PubMed Web of Science ®Google Scholar
• Jørgensen, Jan Trøst. 2012. “Companion Diagnostics and the Drug–Diagnostic Codevelopment Model.” Drug Development Research 73 (3): 390–397. doi: 10.1002/ddr.21029
   Web of Science ®Google Scholar
• Jutel, Annemarie. 2011. Putting a Name to It: Diagnosis in Contemporary Society. Baltimore, MD: Johns Hopkins University Press.
   Google Scholar
• Karapetis, Christos S., Shirin Khambata-Ford, Derek J. Jonker, Chris J. O'Callaghan, Dongsheng Tu, Niall C. Tebbutt, R. John Simes, et al. 2008. “K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer.” The New England Journal of Medicine 359 (17): 1757–1765. doi: 10.1056/NEJMoa0804385
   PubMed Web of Science ®Google Scholar
• Karow, Julia. 2012. “Foundation Medicine to Double Testing Capacity, Show Efficacy of Test in Clinical Trials.” GenomeWeb, June 13. http://www.genomeweb.com/sequencing/foundation-medicine-double-testing-capacity-show-efficacy-test-clinical-trials
   Google Scholar
• Knaapen, Loes, Hervé Cazeneuve, Alberto Cambrosio, Patrick Castel, and Beatrice Fervers. 2010. “Pragmatic Evidence and Textual Arrangements: A Case Study of French Clinical Cancer Guidelines.” Social Science & Medicine 71 (4): 685–692. doi: 10.1016/j.socscimed.2010.05.019
   PubMed Web of Science ®Google Scholar
• Kohli-Laven, Nina, Pascale Bourret, Peter Keating, and Alberto Cambrosio. 2011. “Cancer Clinical Trials in the Era of Genomic Signatures: Biomedical Innovation, Clinical Utility, and Regulatory-Scientific Hybrids.” Social Studies of Science 41 (4): 487–513. doi: 10.1177/0306312711398741
   PubMed Web of Science ®Google Scholar
• Lipson, Doron, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A. Curran, et al. 2012. “Identification of New ALK and RET Gene Fusions from Colorectal and Lung Cancer Biopsies.” Nature Medicine 18 (3): 382–384. doi: 10.1038/nm.2673
   PubMed Web of Science ®Google Scholar
• Lynch, T. J., D. W. Bell, R. Sordella, S. Gurubhagavatula, R. A. Okimoto, B. W. Brannigan, P. L. Harris, et al. 2004. “Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib.” New England Journal of Medicine 350 (21): 2129–2139. doi: 10.1056/NEJMoa040938
   PubMed Web of Science ®Google Scholar
• MacConaill, Laura E., Catarina D. Campbell, Sarah M. Kehoe, Adam J. Bass, Charles Hatton, Lili Niu, Matt Davis, et al. 2009. “Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples.” PLoS ONE 4 (11): e7887. doi: 10.1371/journal.pone.0007887
   PubMed Web of Science ®Google Scholar
• Navon, Daniel. 2011. “Genomic Designation: How Genetics Can Delineate New, Phenotypically Diffuse Medical Categories.” Social Studies of Science 41 (2): 203–226. doi: 10.1177/0306312710391923
   PubMed Web of Science ®Google Scholar
• Nowak, Frédérique, Jean-Charles Soria, and Fabien Calvo. 2012. “Tumour Molecular Profiling for Deciding Therapy – the French Initiative.” Nature Reviews Clinical Oncology 9 (8): 479–486. doi: 10.1038/nrclinonc.2012.42
   PubMed Web of Science ®Google Scholar
• Paez, J. G., Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, et al. 2004. “EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy.” Science 304 (5676): 1497–1500. doi: 10.1126/science.1099314
   PubMed Web of Science ®Google Scholar
• Palmer, G. A., V. A. Miller, J. Curran, J. S. Ross, D. Lipson, Roman Yelensky, P. Stephens, et al. 2012. “Next-Generation Sequencing (NGS) to Identify Actionable Genomic Changes in Common and Rare Solid Tumors: The FMI Experience with the Initial 50 Consecutive Patients”. Poster presented at the American Society of Clinical Oncology Annual Meeting, June 4, Chicago, IL.
   Google Scholar
• Parthasarathy, Shobita. 2007. Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care. Cambridge, MA: MIT Press.
   Google Scholar
• Rabeharisoa, Vololona, and Pascale Bourret. 2009. “Staging and Weighting Evidence in Biomedicine Comparing Clinical Practices in Cancer Genetics and Psychiatric Genetics.” Social Studies of Science 39 (5): 691–715. doi: 10.1177/0306312709103501
   Web of Science ®Google Scholar
• Ray, Turna. 2011. “As More Patients Gain Knowledge of Genetic Makeup, FDA Warns Against Biased Personalized Rx Trials.” GenomeWeb, November 2. http://www.genomeweb.com/mdx/more-patients-gain-knowledge-genetic-makeup-fda-warns-against-biased-personalize
   Google Scholar
• Rosenberg, Charles E. 2002. “The Tyranny of Diagnosis: Specific Entities and Individual Experience.” Milbank Quarterly 80 (2): 237–260. doi: 10.1111/1468-0009.t01-1-00003
   PubMed Web of Science ®Google Scholar
• Roychowdhury, S., M. K. Iyer, D. R. Robinson, R. J. Lonigro, Y.-M. Wu, X. Cao, S. Kalyana-Sundaram, et al. 2011. “Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study.” Science Translational Medicine 3 (111): 111ra121. doi: 10.1126/scitranslmed.3003161
   PubMed Web of Science ®Google Scholar
• Shaw, Alice T., David G. Forcione, Subba R. Digumarthy, and A. John Iafrate. 2011. “Case Records of the Massachusetts General Hospital. Case 21-2011. A 31-Year-Old Man with ALK-positive Adenocarcinoma of the Lung.” The New England Journal of Medicine 364 (2): 158–167. doi: 10.1056/NEJMcpc1004362
   PubMedGoogle Scholar
• Thomas, Uduak Grace. 2013. “Vanderbilt's My Cancer Genome Provides One-stop Data Shop for Cancer Mutations, Therapies, Trials.” GenomeWeb, May 3. http://www.genomeweb.com/informatics/vanderbilts-my-cancer-genome-provides-one-stop-data-shop-cancer-mutations-therap
   Google Scholar
• Tran, B., J. E. Dancey, S. Kamel-Reid, J. D. McPherson, P. L. Bedard, A. M. K. Brown, T. Zhang, et al. 2012. “Cancer Genomics: Technology, Discovery, and Translation.” Journal of Clinical Oncology 30 (6): 647–660. doi: 10.1200/JCO.2011.39.2316
   PubMed Web of Science ®Google Scholar
• Vanderbilt University Medical Center. 2011. “Vanderbilt-Ingram Cancer Center Launches Online Genetic Research Tool”. Press Release, Nashville, TN. http://www.mc.vanderbilt.edu/news/releases.php?release=2039
   Google Scholar
• Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, Brendan Blumenstiel, Matthew DeFelice, Panisa Pochanard, Matthew Ducar, et al. 2012. “High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing.” Cancer Discovery 2 (1): 82–93. doi: 10.1158/2159-8290.CD-11-0184
   PubMed Web of Science ®Google Scholar